Table 6. Numbers of Vaccinee Plasma (VP) neutralization experiments in CoV-RDB according to the vaccine, history of previous infection, time since infection, and SARS-CoV-2 variant tested.
| Characteristic | References | Results |
|---|---|---|
| Vaccine | ||
| BNT162b2 | 121 | 16374 |
| mRNA-1273 | 45 | 5569 |
| CoronaVac | 9 | 1626 |
| AZD1222 | 26 | 2345 |
| Ad26.COV2.S | 13 | 1092 |
| BBV152 | 6 | 569 |
| Sputnik V | 5 | 428 |
| AZD1222 + BNT162b2 | 8 | 544 |
| MVC-COV1901 | 1 | 342 |
| BBV154 | 1 | 120 |
| BBIBP-CorV | 6 | 586 |
| NVX-CoV2373 | 2 | 148 |
| AZD1222 + AZD2816 | 1 | 59 |
| ZF2001 | 2 | 51 |
| mRNA-1273 + mRNA-1273.351 | 2 | 277 |
| AZD2816 | 1 | 20 |
| Previously SARS-CoV-2 infected | ||
| Yes | 34 | 1655 |
| No | 176 | 31885 |
| Time since vaccination | ||
| 1 month | 157 | 27310 |
| 2–3 months | 35 | 3951 |
| 4–6 months | 23 | 1746 |
| > 6 months | 16 | 533 |
| Variant / mutations undergoing neutralization | ||
| Alpha | 92 | 5848 |
| Beta | 106 | 7150 |
| Gamma | 58 | 3247 |
| Delta | 63 | 3764 |
| VOIs (kappa, iota, epsilon, lambda) | 30 | 1484 |
| Other variants | 55 | 3496 |
| Individual mutations and mutation combinations | 78 | 7269 |
| Number of vaccinations | ||
| 1 | 47 | 6742 |
| 2 | 163 | 24506 |
| 3 | 26 | 2292 |
The numbers of references and results obtained from persons receiving uncommonly studied vaccines or vaccine combinations are not shown.